Conaghan, Philip G.
Abraham, Lucy
Viktrup, Lars
Cislo, Paul
Article History
Received: 15 September 2021
Accepted: 3 January 2022
First Online: 1 February 2022
Declarations
:
: The study protocols were approved by the appropriate Institutional Review Board or Independent Ethics Committee at each participating investigational center (main IRB for Study 1: Schulman Associates IRB/Advarra, Ohio, United States; for Study 2, see supplementary AppendixInternalRef removed). All patients provided written informed consent prior to entering the studies. The studies were conducted in compliance with the Declaration of Helsinki and International Conference on Harmonisation Good Clinical Practice Guidelines.
: Not applicable.
: PGC has done consultancies or speakers bureaus for AbbVie, AstraZeneca, EMD Serono, Flexion Therapeutics, Galapagos, Gilead, Novartis, and Pfizer. LA and PC are employees of Pfizer with stock and/or stock options. LV is an employee of Eli Lilly and Company and owns stock in Lilly.